Some differences were observed when grouping by ESRD etiology, as more frequent risk of graft thrombosis in the PCKD group, more frequent risk of infection of the surgical wound, Cytomegalovirus (CMV) infections and delayed graft function in the DN group, and more frequent urinary infections in the LN group were observed.
2%/person-year) in the PCKD group (one due to acute rejection, one due to a vascular cause and three due to death).
Differences were not significant in the outcome of the PCKD group compared with those in the other two groups.
In our study, patient survival was lower in the DN population than in the LN and PCKD groups (a 75.
In turn, age, the number of HLA incompatibilities, time in dialysis, time in cold ischemia, type of immunosuppression therapy and the disease causing ESRD (LN, PCKD and DN) did not affect graft survival.